HSBC Holdings
ALT icon

HSBC Holdings’s Altimmune ALT Stock Holding History

HSBC Holdings’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476K Buy
154,365
+22,144
+17% +$94K ﹤0.01% 2244
2025
Q4 		$474K Buy
132,221
+59,095
+81% +$258K ﹤0.01% 2346
2025
Q3 		$272K Sell
73,126
-12,342
-14% -$47.7K ﹤0.01% 2368
2025
Q2 		$329K Buy
85,468
+13,210
+18% +$71.5K ﹤0.01% 2384
2025
Q1 		$349K Buy
+72,258
New +$458K ﹤0.01% 2283
2020
Q3 		– Sell
-21,326
Closed -$228K – 2712
2020
Q2 		$228K Buy
+21,326
New +$117K ﹤0.01% 2282
2017
Q1 		– Sell
-36
Closed -$35K – 2125
2016
Q4 		$35K Buy
+36
New +$32.3K ﹤0.01% 2683

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HSBC Holdings's ALT Position: Q1 2026 in Review

HSBC Holdings increased its Altimmune (ALT) stake by 17% in Q1 2026, buying an estimated $94K and bringing the position to 154,365 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

HSBC Holdings first reported a position in ALT in Q4 2016 and has held it in 7 quarters since. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • HSBC Holdings held 154,365 shares of Altimmune worth $476K as of Q1 2026.
  • HSBC Holdings bought 22,144 Altimmune shares in Q1 2026, an estimated $94K.
  • Altimmune made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2244 holding.
  • HSBC Holdings first reported a position in Altimmune in Q4 2016 and has held it in 7 quarters since.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.